COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

May 29, 2020

The amount of cytokine-release defines different shades of Sars-Cov2 infection

Experimental Biology and Medicine
S BindoliA Doria
May 28, 2020
Review

Lymphopenia in COVID-19: Therapeutic Opportunities

Cell Biology International
Nazanin Fathi, Nima Rezaei
May 31, 2020
Review

Treatment algorithm for COVID-19: a multidisciplinary point of view

Clinical Rheumatology
Felice GalluccioMario Fajardo-Pérez
May 30, 2020
Review

Emerging pharmacotherapies for COVID-19

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Rachana Salvi, Panini Patankar
May 31, 2020

Cytokine storm in COVID-19 and parthenolide: preclinical evidence

Phytotherapy Research : PTR
Mohsen BahramiMajid Dadmehr
May 29, 2020

COVID-19: Consider IL6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients

Journal of Medical Virology
Chiranjib ChakrabortyGovindasamy Agoramoorthy
May 31, 2020
Review

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

International Journal of Molecular Sciences
Francesca RossiFrancesca Punzo
May 28, 2020

Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days

Dermatologic Therapy
Ayse Serap KaradagUwe Wollina
May 28, 2020
ReviewOpen Access

Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19

Journal of Cardiovascular Translational Research
Marat FudimLuis Ulloa
May 31, 2020
Review

Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19

International Journal of Molecular Sciences
Isabella OrientiGiovanna Farruggia
June 1, 2020
Review

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Clinical Rheumatology
Mehmet SoyServet Kayhan
May 27, 2020

Pediatric Crohn's Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab

Journal of Pediatric Gastroenterology and Nutrition
Michael T DolingerJoanne Lai
May 30, 2020

Why does COVID-19 disproportionately affect older people?

Aging
Amber L MuellerDavid A Sinclair

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Neurologic Manifestations

COVID-19 patients frequently have neurological symptoms, which are probably caused by the virus invading the central nervous system. Symptoms range from a loss of smell and taste to serious complications such as encephalitis, many of which are associated with poor prognosis. This feed follows the latest developments and research into the neurological complications associated with COVID-19.

© 2020 Meta ULC. All rights reserved
/feed-previews/covid-19-immunopathology/718c2c4e-a9c3-40c6-b6e9-5bab37fa1658